Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Costa

Showing results (241-250 of 311) with videos related to

Pageof 32
Sort By:
Spine|May 7, 2025
Basilar Invagination Diagnosis, Classification, and Radiology: WFNS Spine Committee RecommendationsOnur Yaman, Mehmet Zileli, İdris Avci, et al.
Expert Opinion on Biological Therapy|October 19, 2020
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patientsDaniela Pugliese, Luisa Guidi, Giuseppe Privitera, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 11, 2025
Transthyretin amyloid deposition in the ligamentum flavum of an Italian cohort of patients with lumbar spinal stenosisFrancesca Vitali, Silvia Fenu, Alessandro Izzo, et al.
Inflammatory Bowel Diseases|June 12, 2024
Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn's Disease: A Prospective Pilot StudyLorenzo Bertani, Luca Antonioli, Marco Fornili, et al.
Therapeutic Advances in Gastroenterology|August 5, 2021
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian studyBrigida Barberio, Linda Cingolani, Cristina Canova, et al.
Journal of Clinical Medicine|January 11, 2024
Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionFelice Gragnano, Antonio Capolongo, Antonio Micari, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 8, 2022
Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumabLorenzo Bertani, Brigida Barberio, Marco Fornili, et al.
The Journal of Biological Chemistry|July 3, 2003
Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitorLior Zilberberg, Svetlana Shinkaruk, Olivier Lequin, et al.
European Heart Journal|July 15, 2025
Artificial intelligence in cardiovascular pharmacotherapy: applications and perspectivesFrancesco Costa, Juan Jose Gomez Doblas, Arancha Díaz Expósito, et al.
Medicina (Kaunas, Lithuania)|November 27, 2025
Coronary Intravascular Imaging: A Comprehensive Review of Techniques, Applications, and Future DirectionsGiustina Iuvara, Marco Franzino, Gabriele Carciotto, et al.
Pageof 32

Showing results (241-250 of 311) with videos related to

Sort By:
Pageof 32
Spine|May 7, 2025
Basilar Invagination Diagnosis, Classification, and Radiology: WFNS Spine Committee RecommendationsOnur Yaman, Mehmet Zileli, İdris Avci, et al.
Expert Opinion on Biological Therapy|October 19, 2020
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patientsDaniela Pugliese, Luisa Guidi, Giuseppe Privitera, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 11, 2025
Transthyretin amyloid deposition in the ligamentum flavum of an Italian cohort of patients with lumbar spinal stenosisFrancesca Vitali, Silvia Fenu, Alessandro Izzo, et al.
Inflammatory Bowel Diseases|June 12, 2024
Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn's Disease: A Prospective Pilot StudyLorenzo Bertani, Luca Antonioli, Marco Fornili, et al.
Therapeutic Advances in Gastroenterology|August 5, 2021
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian studyBrigida Barberio, Linda Cingolani, Cristina Canova, et al.
Journal of Clinical Medicine|January 11, 2024
Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionFelice Gragnano, Antonio Capolongo, Antonio Micari, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 8, 2022
Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumabLorenzo Bertani, Brigida Barberio, Marco Fornili, et al.
The Journal of Biological Chemistry|July 3, 2003
Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitorLior Zilberberg, Svetlana Shinkaruk, Olivier Lequin, et al.
European Heart Journal|July 15, 2025
Artificial intelligence in cardiovascular pharmacotherapy: applications and perspectivesFrancesco Costa, Juan Jose Gomez Doblas, Arancha Díaz Expósito, et al.
Medicina (Kaunas, Lithuania)|November 27, 2025
Coronary Intravascular Imaging: A Comprehensive Review of Techniques, Applications, and Future DirectionsGiustina Iuvara, Marco Franzino, Gabriele Carciotto, et al.
Pageof 32